Weight gain affects the efficacy of antidepressants, new study finds

Weight gain is a side effect of antidepressants, adding another layer of problems.

two women walking away

A woman helps an overweight person on April 12, 2016 in Berck-sur-Mer, northern France.

Photo: Philippe Huguen/AFP via Getty Images
  • A comprehensive scoping review of 12 studies found that being overweight negatively affects the efficacy of antidepressants.
  • McGill University researchers investigated SSRIs, SNRIs, tricyclic antidepressants, and tetracyclic antidepressants.
  • A double-edged sword: Obesity impacts antidepressants, yet a side effect of these drugs is weight gain.

The initial European trials for gaboxadol produced positive results. Merck and Lundbeck were convinced they had a blockbuster drug on their hands. Researchers considered it a major improvement over Ambien, which sometimes left users feeling groggy the next day. Gaboxadol also didn't produce negative effects when mixed with alcohol, making it a rare sleeping pill. Then the U.S. trials began.

The drug bombed. In 2007, the pharmaceutical giants canceled development of the drug; Lundbeck sold the rights to it in 2015. While no specific reason for its failure has been stated, pharmacology professor Richard J Miller writes that the protein molecule that carries gaboxadol also transports amino acids, such as tryptophan, across the blood-brain barrier. Since Americans consume 20 percent more daily calories from meat than Europeans, gaboxadol likely failed because it was competing with extra tryptophan.

Drugs are complex. A one-size-fits-all approach to drug development often doesn't work. If gaboxadol works for vegetarians, should it be reconsidered? Perhaps in a research field focused on individualized medicine, but that's not the system we live in. Gaboxadol is now being studied for use in treatments of Fragile X syndrome and Angelman syndrome.

There are many reasons a drug might work for you and not me. This is true of antibiotics and vaccines, though these classes of drugs have a solid track record. When considering more controversial treatments, such as antidepressants, the story changes.

Antidepressants Make it Harder to Empathize, Harder to Climax, and Harder to Cry. | Julie Holland

Add to this tale a new study, published in Journal of Affective Disorders, investigating the efficacy of antidepressants in overweight users. A team at McGill University reviewed 12 studies that focused on SSRIs, SNRIs, tricyclic antidepressants, and tetracyclic antidepressants conducted between 2004-2019. Eleven of them found that weight class or body mass index (BMI) negatively affects the efficacy of these antidepressants.

This comprehensive scoping review from the McGill team is troubling for two reasons. First, obesity is already a predictor for depression. Second, weight gain is also a side effect of antidepressants, implying that their efficacy could dwindle with long-term usage. Recent evidence confirms that extended usage of antidepressants results in withdrawal symptoms that persist for over a year, obesity included in that list.

According to the study, over 300 million people suffer from depression around the world. The WHO reports that depression is the leading cause of disability worldwide. Pharmaceutical intervention is problematic with roughly half of prescription users. While the reasons for this are not well understood, obese and overweight patients suffer from treatment-resistant depression at higher rates than those with normal weight.

man sitting in a chair holding his head

Photo by Nik Shuliahin on Unsplash

The researchers offer a few possibilities for why being overweight could negatively affect antidepressants.

  • Antidepressants might not dissolve as effectively in increased body fat.
  • Variations in plasma concentrations are caused by extra adipose tissue.
  • Obese patients are more likely to be on other drugs, any of which could effect the efficacy of antidepressants.
  • Obesity is a state of systemic low grade inflammation that impacts how drugs act in the body.
  • Excess adipose tissue secretes more adipokines, suppressing neurotransmitter systems.
  • Levels of leptin, the hormone that signals hunger, are compromised as weight gain increases.
  • Genetic factors, such as neurotransmitter receptors and drug metabolizing enzymes, could play a role.
  • Comorbid medical conditions—sleep apnea, asthma, metabolic syndrome—can contribute to depression as well as dampen the response to medications.

This wide range of potential factors shows the complexity of drug interactions within the human body. One thing is clear from the McGill team's review: being overweight reduces the efficacy of the world's most popular antidepressants. This trend reiterates the need for better mental treatments, such as psychotherapy and psychedelic therapy. The time for an overhaul of the psychiatry industry and its reliance on this class of drugs has come.


Stay in touch with Derek on Twitter, Facebook and Substack. His next book is "Hero's Dose: The Case For Psychedelics in Ritual and Therapy."

Malcolm Gladwell live | How to re-examine everything you know

Join Radiolab's Latif Nasser at 1pm ET on Monday as he chats with Malcolm Gladwell live on Big Think.

Big Think LIVE

Add event to your calendar

AppleGoogleOffice 365OutlookOutlook.comYahoo

Keep reading Show less

Humans evolved for punching, study confirms

University of Utah research finds that men are especially well suited for fisticuffs.

Image source: durantelallera/Shutterstock
Surprising Science
  • With males having more upper-body mass than women, a study looks to find the reason.
  • The study is based on the assumption that men have been fighters for so long that evolution has selected those best-equipped for the task.
  • If men fought other men, winners would have survived and reproduced, losers not so much.
Keep reading Show less

To be a great innovator, learn to embrace and thrive in uncertainty

Innovators don't ignore risk; they are just better able to analyze it in uncertain situations.

David McNew/Getty Images
Personal Growth
Madam C.J. Walker, born Sarah Breedlove, was America's first female self-made millionaire.
Keep reading Show less

Study: Private prisons result in more inmates, longer sentences

The Labour Economics study suggests two potential reasons for the increase: corruption and increased capacity.

Politics & Current Affairs
  • After adopting strict sentencing laws in the '80s and '90s, many states have turned to for-profit prisons to handle growing prison populations.
  • A new study in Labour Economics found that privately-run prisons correlate with a rise in incarceration rates and sentence lengths.
  • While evidence is mixed, private prisons do not appear to improve recidivism or cost less than state-run facilities.
  • Keep reading Show less

    The art of asking the right questions

    What exactly does "questions are the new answers" mean?

    Scroll down to load more…